valette ethinyloestradiol / dienogest tablet blister pack
bayer australia ltd - dienogest, quantity: 2 mg; ethinylestradiol, quantity: 0.03 mg - tablet, sugar coated - excipient ingredients: calcium carbonate; ferric oxide; macrogol 6000; glycol montanate; glycerol; sucrose; lactose monohydrate; maize starch; povidone; titanium dioxide; purified talc; magnesium stearate - valette is indicated for use as an oral contraceptive and in the treatment of mild to moderate acne in women who seek oral contraception.
diane 35
bayer israel ltd - cyproterone acetate; ethinylestradiol - tablets - ethinylestradiol 35 mcg; cyproterone acetate 2 mg - cyproterone and estrogen - cyproterone and estrogen - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.
microgynon 30
bayer israel ltd - ethinylestradiol; levonorgestrel - coated tablets - levonorgestrel 150 mcg; ethinylestradiol 30 mcg - progestogens and estrogens, fixed combinations - oral contraceptive.
diane-35
bayer new zealand limited - cyproterone acetate 2mg; ; ethinylestradiol 0.035mg - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sucrose titanium dioxide
femodene 21
bayer new zealand limited - ethinylestradiol 0.03mg; gestodene 0.075mg - tablet - active: ethinylestradiol 0.03mg gestodene 0.075mg excipient: calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sodium calcium edetate sucrose
femodene ed
bayer new zealand limited - ethinylestradiol 0.03mg; gestodene 0.075mg - tablet - active: ethinylestradiol 0.03mg gestodene 0.075mg excipient: calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sodium calcium edetate sucrose lactose monohydrate
harmonet 21
wyeth (nz) ltd - ethinylestradiol 20ug; gestodene 75ug; - tablet - active: ethinylestradiol 20ug gestodene 75ug excipient: calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sucrose
ismo 40 retard
pharmacy retailing (nz) ltd t/a healthcare logistics - isosorbide mononitrate 40mg (as ismo extended release premix 49.2%) - modified release tablet - 40 mg - active: isosorbide mononitrate 40mg (as ismo extended release premix 49.2%) excipient: colloidal silicon dioxide as ismo extended release premix 49.2% glucose liquid glycol montanate kaolin lactose as ismo extended release premix 49.2% macrogol 35000 magnesium stearate as ismo extended release premix 49.2% methacrylic acid copolymer povidone purified talc sucrose titanium dioxide - long-term treatment of coronary heart disease (chd)
loette 21
wyeth (nz) ltd - ethinylestradiol 20ug; levonorgestrel 100ug - film coated tablet - active: ethinylestradiol 20ug levonorgestrel 100ug excipient: glycol montanate lactose monohydrate macrogols magnesium stearate microcrystalline cellulose opadry pink ys-1-14587-a polacrilin potassium
melodene
bayer new zealand limited - ethinylestradiol 0.02mg; gestodene 0.075mg - tablet - active: ethinylestradiol 0.02mg gestodene 0.075mg excipient: calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sucrose